Form 4 for ELV Elevance Health
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001156039-25-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | ELV | Kaye Mark | EVP, CFO | F - Tax | $395.50 | -270 | 20.0K | -1% | -$106.8K |
| D | 2025-03-05 | 2025-03-03 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +3,604 | 23.6K | +18% | $0 |
| D | 2025-03-05 | 2025-03-03 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +13.7K | 13.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | F | D | 270 | $395.50 | 19,961 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 2 | Common | Common Stock | 2025-03-03 | A | A | 3,604 | $0.00 | 23,565 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows:1,201 shares each on 3/3/2026 and 3/3/2027, and 1,202 shares on 3/3/2028. (F3) Balance includes 17.59 shares acquired on December 20, 2024 through a dividend reinvestment plan. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2025-03-03 | A | A | 13,713 | $0.00 | 13,713 | D | $395.50 · — to 2035-03-03 | 13,713 Common Stock | (F4) The option represents a right to purchase a total of 13,713 shares, and is exercisable in three annual installments of 4,571 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date. |